Library
Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers.
1 December 2000.
Burggraaf J, Schoemaker RC, Lentjes EG, Cohen AF
View publicationSorbitol has been suggested as a suitable marker to assess liver blood flow (LBF), after it was shown to adequately reflect prolonged changes in LBF but changes of a shorter duration have not been investigated. We therefore used sorbitol to evaluate drug-induced decreases in LBF of variable duration with i.v. infusions of somatostatin and its synthetic analogue octreotide.
Advancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
